Member Info for Hurst10

Add all the post hours volume up which has been done over the week!

Much more to come.

Lilly failing to get enough support for their takeover of Point, not surprised with : Point Biopharma is a developer of radioligand therapy, a targeted cancer treatment which uses a combination of molecules that attach themselves to the tumors and radioactive particles that kill the specific cells.

The company expects results from its late-stage study of experimental therapy, PNT2002, to treat a type of advanced prostate cancer later this month.Expect Point Biopharma’s share price to go north and Avacta’s JV to look even more interested.

Not surprised if Lilly choose to focus on Avacta instead.

Good.

Watch out for size buy orders.

1.6 mill traded !!

Watch the opening.

Interesting size prints post hours

Good luck !

However the share price will react and move higher !

Let us see in 7 days time!

150-5 for starters !

Good luck to your strategy.

Meanwhile let us watch next week, upwards we move and much news!!

Just stay on board and you will be rewarded.

Not day trading ! The real buyers have barely begun.

Good luck.

Follow the money!

The buyer is not going away.

Should have jumped onboard at 109 and enjoined a very nice rally indeed.

We have barely begun however, plenty more to come!

Watch the rally begin before US opens and two hours left before we have a week starting , which could be very interesting indeed!

Further to Novartis’ investor / strategy day, interesting to note that

The chairman Eliot Foster is taking up a new CEO role as well( today’s RNS), the Chairman clearly aware of potential change of the structure of management of Avacta, with several majors knocking on the door!

More late prints from this AM at +140p.

Warming up nicely for more news, try and get size below 145p

Look at the Bristol Myers deal announced today with Avidity.

$100 mill upfront + further payments up to $2.3 billion.

Non market prints at 142.85 ( size) from early trade being shown.

Note the post hours prints !

US opening - size buyer back in town.

It is not a question of follow the money, but follow the volume and then listen to what the company tells at AGM’ s etc.

Fiona McLaughlin’s presentation in Boston and what companies like Lilly is up to!

We got a company who I have always said it is the best thing out of Cambridge ( used to have office there) since ARM holdings.

There is a persistent buyer in the market and now will seriously have the majors stop taking no for an answer.

Avacta has told us once latest Cohort is out, next stop is a licensed deal and reorganise the company ( diagnostics) and we are off to the races.It is Friday, next week will heavy volume and suddenly no sellers. Classic situation! Seen it many times before, why do you think management have not been selling!

You have 30 min left and that will be the last time you can get in at these prices.Get on board and the trick is not to sell too early!!

Look at some of the US Biotech stocks and what happen to them.

Who can out bid most of the others ? JNJ is one of them.

Good luck, but buy now !!

Most of us must be up + 30% from the latest round and you will now look out for size lifting offer at 38, straight through 140, with a nice two hour Friday closing rally!

The trick is not to sell, too much happening and will happen.

Monday the Market will struggle to control the opening price and if you chaps knows anything about a fast moving market and bid price higher than offer, well that is what you will see next week.

Wait for the other side of last hour’s trades pops up, before earlybird NY gets involved!